Virus cancer link examined

New findings complicate recent evidence for a viral link to prostate cancer. linkurl:Recent studies;http://www.the-scientist.com/news/display/55966/ have found the virus, called xenotropic murine leukemia virus-related virus (XMRV), in a disproportionate number of cancer tissue samples in men with prostate cancer, but the linkurl:latest report,;http://www.retrovirology.com/content/6/1/92 published today (October 16) in Retrovirology, detected no sign of XMRV in tissue samples from almost 600 pro

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share
New findings complicate recent evidence for a viral link to prostate cancer. linkurl:Recent studies;http://www.the-scientist.com/news/display/55966/ have found the virus, called xenotropic murine leukemia virus-related virus (XMRV), in a disproportionate number of cancer tissue samples in men with prostate cancer, but the linkurl:latest report,;http://www.retrovirology.com/content/6/1/92 published today (October 16) in Retrovirology, detected no sign of XMRV in tissue samples from almost 600 prostate cancer patients.
Prostate cancer cells
Image: Wikipedia
"The association [of XMRV] to prostate cancer will require many large screening studies done on various populations across the world," linkurl:Joseph DeRisi,;http://www.hhmi.org/research/investigators/derisi_bio.html a biochemist and biophysicist at the University of California, San Francisco, who was not involved in the study, said in an email. "This would be one of many, and I don't expect everyone to get the same results." Prostate cancer is one of the leading causes of cancer deaths in men, but researchers have a limited understanding of what triggers it. In 2006, DeRisi and his colleagues were the first to identify linkurl:XMRV infection as a potential risk factor,;http://www.ncbi.nlm.nih.gov/pubmed/16609730 showing that the virus was present in up to 40% of the prostate tumor samples they studied. Last month, linkurl:a study in PNAS;http://www.pnas.org/cgi/doi/10.1073/pnas.0906922106 reported that viral DNA or proteins were present in more than a quarter of 334 prostate cancer tissue samples they studied. XMRV is similar to viruses already known to cause cancer in animals, and these results led some to postulate that prostate cancer, like cervical cancer, may be a sexually transmitted disease. In the present study, researchers at the Robert Koch Institute and the medical school Charité - Universitätsmedizin Berlin in Germany collected tissue samples from 589 German prostate cancer patients between 2000 and 2006. They screened the patients' DNA and RNA for signs of XMRV using real-time PCR, a method for detecting and amplifying a specific sequence in a DNA or RNA sample, and also used assays to look for antibodies specific for XMRV. The study authors found that none of the tumor samples contained XMRV, and assays showed no XMRV antibodies in the blood. There are several other studies that have failed to find XMRV in prostate tumor samples. "Our results are in agreement with linkurl:another study;http://linkinghub.elsevier.com/retrieve/pii/S1386653208003016 investigating the prevalence of the virus in German prostate cancer patients," linkurl:Oliver Hohn of the Robert Koch Institute,;http://www.rki.de/ the current study's first author, wrote in an email. In the 2008 study he referred to, XMRV was detected in only one of 105 prostate tumor samples. "Knowing these data, our results were not too surprising," Hohn said. In addition, he noted, researchers from Ireland reported at the 2008 European Association of Urology conference in Milan that they also found no XMRV in prostate cancer patients. "It is possible that the methods used may have missed detecting XMRV," said linkurl:Robert Silverman,;http://www.lerner.ccf.org/cancerbio/silverman/ a cancer researcher at the Lerner Research Institute in Ohio and an author on last month's PNAS study. Silverman said that the PCR methods used in this paper are significantly less sensitive than the ones he has used in patient samples. Hohn, however, said that he and his team developed specific and highly sensitive PCR assays to detect the viral genome. Another explanation for the discrepancy between studies, noted Hohn, is that XMRV may be more prevalent in the US than in Germany. DeRisi agreed. "If this is a real infection, I highly doubt it would have globally uniform distribution," said DeRisi, who is also a Howard Hughes Medical Institute investigator. "So not finding it in Germany may imply that this could be geographically restricted or be transmitted in a way that is not occurring there."
**__Related stories:__***linkurl:Viral cause for prostate cancer?;http://www.the-scientist.com/news/display/55966/
[7th September 2009]*linkurl:Silenced genes drive viral cancers?;http://www.the-scientist.com/blog/display/55410/
[9th February 2009]*linkurl:When cancer is just the beginning;http://www.the-scientist.com/article/display/55048/
[October 2008]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Victoria Stern

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio